 Connection
Zachary Walker to Humans
This is a "connection" page, showing publications Zachary Walker has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.111 |
|
|
|
-
Walker ZJ, Vaeth KF, Baldwin A, Ohlstrom DJ, Reiman LT, Dennis KA, Matlin K, Idler BM, Stevens BM, Mukherjee N, Sherbenou DW. Ribosome Profiling Reveals Translational Reprogramming via mTOR Activation in Omacetaxine-Resistant Multiple Myeloma. Mol Cancer Res. 2025 07 02; 23(7):611-621.
Score: 0.022
-
Naert M, Sorouri K, Lanes A, Kempf AM, Chen L, Goldman R, Partridge AH, Ginsburg E, Srouji SS, Walker Z. Impact of a Nurse Navigator Program on Referral Rates and Use of Fertility Preservation Among Female Cancer Patients: A 14-Year Retrospective Cohort Study. Cancer Med. 2025 Feb; 14(3):e70529.
Score: 0.022
-
Walker ZJ, Idler BM, Davis LN, Stevens BM, VanWyngarden MJ, Ohlstrom D, Bearrows SC, Hammes A, Smith CA, Jordan CT, Mark TM, Forsberg PA, Sherbenou DW. Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy. Clin Cancer Res. 2021 02 01; 27(3):819-830.
Score: 0.016
-
Walker ZJ, VanWyngarden MJ, Stevens BM, Abbott D, Hammes A, Langouët-Astrie C, Smith CA, Palmer BE, Forsberg PA, Mark TM, Jordan CT, Sherbenou DW. Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression. Blood Adv. 2020 04 28; 4(8):1628-1639.
Score: 0.016
-
Saiduzzaman SM, Xu R, Sampad MJN, Hoffman RN, Seiler ST, Brail Q, Yurevych V, Walker ZJ, Wells TN, Ong EM, Yuzvinsky TD, Hawkins AR, Salama SR, Teodorescu M, Haussler D, Schmidt H. Single molecule nanopore counting assay targeting small extracellular vesicle cargo for non-invasive monitoring of cerebral organoid development and health. Sci Rep. 2025 12 12; 15(1):45806.
Score: 0.006
-
Ohlstrom D, Walker ZJ, Pandey A, Davis LN, Engel KL, Pan Z, Forsberg PA, Mark TM, Gillen AE, Sherbenou DW. Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression. Cancer Res Commun. 2025 01 01; 5(1):106-118.
Score: 0.005
-
Day CC, Landguth EL, Sawaya MA, Clevenger AP, Long RA, Holden ZA, Akins JR, Anderson RB, Aubry KB, Barrueto M, Bjornlie NL, Copeland JP, Fisher JT, Forshner A, Gude JA, Hausleitner D, Heim NA, Heinemeyer KS, Hubbs A, Inman RM, Jackson S, Jokinen M, Kluge NP, Kortello A, Lacroix DL, Lamar L, Larson LI, Lewis JC, Lockman D, Lucid MK, MacKay P, Magoun AJ, McLellan ML, Moriarty KM, Mosby CE, Mowat G, Nietvelt CG, Paetkau D, Palm EC, Paul KJS, Pilgrim KL, Raley CM, Schwartz MK, Scrafford MA, Squires JR, Walker ZJ, Waller JS, Weir RD, Zeller KA. Genetic connectivity of wolverines in western North America. Sci Rep. 2024 11 15; 14(1):28248.
Score: 0.005
-
Robbins LS, Szychowski JM, Nassel A, Bansal A, Oben AG, Armour EK, Walker Z, Rajapreyar IN, Wingate M, Tita AT, Sinkey RG. Social Vulnerability May Underlie Racial Disparities in Peripartum Cardiomyopathy Outcomes. Ethn Dis. 2024 08; 34(3):173-178.
Score: 0.005
-
Davis LN, Walker ZJ, Reiman LT, Parzych SE, Stevens BM, Jordan CT, Forsberg PA, Sherbenou DW. MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance. Clin Cancer Res. 2024 Jul 15; 30(14):3023-3035.
Score: 0.005
-
Perez de Acha O, Reiman L, Jayabalan DS, Walker ZJ, Bosma G, Keller AL, Parzych SE, Abbott D, Idler BM, Ribadeneyra D, Niesvizky R, Forsberg PA, Mark TM, Sherbenou DW. CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies. Blood Adv. 2023 11 14; 7(21):6430-6440.
Score: 0.005
-
Reed JL, Walker ZJ, Basu D, Allen V, Nicol MP, Kelso DM, McFall SM. Highly sensitive sequence specific qPCR detection of Mycobacterium tuberculosis complex in respiratory specimens. Tuberculosis (Edinb). 2016 12; 101:114-124.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|